Published in Clin Gastroenterol Hepatol on March 10, 2009
Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease | NCT01572974
Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ (2010) 3.44
ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol (2015) 3.22
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
Quality of life following radiofrequency ablation of dysplastic Barrett's esophagus. Endoscopy (2010) 1.75
The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus. Dig Dis Sci (2010) 1.65
Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy. BMC Health Serv Res (2012) 1.15
Epigenetic biomarkers in esophageal cancer. Cancer Lett (2012) 1.01
Ablative therapies for Barrett's esophagus. Curr Gastroenterol Rep (2011) 0.88
Screening for Barrett's esophagus: results from a population-based survey. Dig Dis Sci (2014) 0.79
Barrett's Esophagus: Emerging Knowledge and Management Strategies. Patholog Res Int (2012) 0.78
A 52-year-old man with heartburn: should he undergo screening for Barrett's esophagus? Clin Gastroenterol Hepatol (2009) 0.78
Health-related quality of life in patients with Barrett's esophagus. Health Qual Life Outcomes (2016) 0.75
Low grade dysplasia in Barrett's esophagus: Should we worry? World J Gastrointest Pathophysiol (2014) 0.75
Development of the Northwestern Esophageal Quality of Life Scale: A Hybrid Measure for Use Across Esophageal Conditions. Am J Gastroenterol (2016) 0.75
Patient experiences with surveillance endoscopy: a qualitative study. Dig Dis Sci (2014) 0.75
Morbidity and mortality after surgery for nonmalignant colorectal polyps. Gastrointest Endosc (2017) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care (1993) 27.05
Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg (1950) 9.92
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
Methods to explain the clinical significance of health status measures. Mayo Clin Proc (2002) 7.00
Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology (2005) 5.77
The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry (1976) 5.12
The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol (1997) 4.52
The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med (1985) 4.30
Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg (1995) 3.64
Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology (1987) 3.56
Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA (2002) 3.11
The oesophagus lined with gastric mucous membrane. Thorax (1953) 2.74
Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol (1995) 2.73
Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology (2003) 2.59
The impact of diagnosis of hepatitis C virus on quality of life. Hepatology (1999) 2.32
The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol (1999) 2.26
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26
Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol (2003) 2.21
Patients with Barrett's esophagus perceive their risk of developing esophageal adenocarcinoma as low. Gastrointest Endosc (2007) 2.18
Health-related quality of life of subjects with known and unknown hypertension: results from the population-based Hortega study. J Hypertens (2003) 2.12
Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology (2005) 2.07
The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program. Gastroenterology (2005) 1.91
Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. Am J Med (2001) 1.91
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis (2004) 1.88
The development of the GERD-HRQL symptom severity instrument. Dis Esophagus (2007) 1.80
Patient-derived health state utilities for gastroesophageal reflux disease. Am J Gastroenterol (2005) 1.64
Mortality in Barrett's oesophagus: results from a population based study. Gut (2003) 1.60
Laparoscopic fundoplication. Surg Endosc (2001) 1.47
Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases. Scand J Gastroenterol Suppl (1993) 1.47
Quality of life measurement in gastroenterology: what is available? Am J Gastroenterol (2001) 1.17
Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Am J Gastroenterol (2000) 1.14
The burden of upper gastrointestinal endoscopy in patients with Barrett's esophagus. Endoscopy (2006) 1.13
Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Dis Esophagus (2000) 1.03
Managing gastroesophageal reflux disease in primary care: the patient perspective. J Am Board Fam Pract (2005) 1.02
Making quality-of-life results more meaningful for clinicians. Lancet (2008) 0.98
Different perceptions of the burden of upper GI endoscopy: an empirical study in three patient groups. Qual Life Res (2007) 0.96
Effect of a new diagnosis of Barrett's esophagus on insurance status. Am J Gastroenterol (2005) 0.95
Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus. Dig Liver Dis (2005) 0.90
The economic and quality-of-life impact of symptomatic gastroesophageal reflux disease. Am J Gastroenterol (2003) 0.90
Quality of life in patients with Barrett's esophagus undergoing surveillance. Am J Gastroenterol (2002) 0.90
Measuring health-related quality of life in patients with upper gastrointestinal disease. Dig Dis (1999) 0.89
The impact of gastroesophageal reflux disease on quality of life. Surg Endosc (2003) 0.89
Health-related quality of life: a primer for gastroenterologists. Am J Gastroenterol (1999) 0.88
Does cancer risk affect health-related quality of life in patients with Barrett's esophagus? Gastrointest Endosc (2007) 0.85
Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa. Aliment Pharmacol Ther (2006) 0.84
Quality of life in patients with various Barrett's esophagus associated health states. Health Qual Life Outcomes (2006) 0.84
The economic burden of Barrett's esophagus in a Medicaid population. Ann Pharmacother (2002) 0.84
Update on health-related quality of life in patients with gastroesophageal reflux disease. Expert Rev Pharmacoecon Outcomes Res (2003) 0.83
Young patients with Barrett's oesophagus experience less reflux complaints. Digestion (2001) 0.79
Laparoscopic antireflux surgery: disease-related quality of life assessment before and after surgery in GERD patients with and without Barrett's esophagus. Surg Endosc (2003) 0.78
Defining a clinically significant adverse impact of diagnosing Barrett's esophagus. J Clin Gastroenterol (2006) 0.78
A cost analysis of outpatient care for patients with Barrett's esophagus in a managed care setting. Am J Gastroenterol (1999) 0.77
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15
Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med (2011) 6.79
American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc (2010) 3.74
A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology (2004) 3.50
Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc (2008) 3.13
Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol (2007) 2.94
American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology (2008) 2.79
Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis. Am J Gastroenterol (2012) 2.70
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2009) 2.53
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol (2011) 2.47
Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol (2009) 2.46
Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 2.28
American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology (2008) 2.23
Digestive and liver diseases statistics, 2004. Gastroenterology (2004) 2.14
Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med (2009) 2.11
Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06
Applying a natural language processing tool to electronic health records to assess performance on colonoscopy quality measures. Gastrointest Endosc (2012) 1.96
A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology (2009) 1.95
Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study. Gastrointest Endosc (2011) 1.82
Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc (2010) 1.79
Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol (2013) 1.75
Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Am J Gastroenterol (2003) 1.73
Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia. Dig Dis Sci (2009) 1.70
Single and multiple dose pharmacokinetics of maraviroc in saliva, semen, and rectal tissue of healthy HIV-negative men. J Infect Dis (2011) 1.70
Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. Gastrointest Endosc (2012) 1.67
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67
Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospital. J Clin Gastroenterol (2011) 1.66
Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology (2012) 1.65
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res (2009) 1.65
The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol (2012) 1.64
Impact of nighttime and weekend liver transplants on graft and patient outcomes. Liver Transpl (2012) 1.60
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52
Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium. Gut (2013) 1.52
The impact of the changing health care environment on the health and well-being of faculty at four medical schools. Acad Med (2006) 1.50
A 25-year analysis of the American College of Gastroenterology research grant program: factors associated with publication and advancement in academics. Am J Gastroenterol (2009) 1.49
Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc (2011) 1.49
Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology (2010) 1.48
Barrett's esophagus and the costs of "doing something". Gastrointest Endosc (2007) 1.47
Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc (2012) 1.46
Single nucleotide polymorphisms of caudal type homeobox 1 and 2 are associated with Barrett's esophagus. Dig Dis Sci (2013) 1.42
Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival? J Clin Oncol (2005) 1.40
A cross-sectional analysis of the prevalence of Barrett esophagus in otolaryngology patients with laryngeal symptoms. J Clin Gastroenterol (2013) 1.40
Design and validation of an angle-resolved low-coherence interferometry fiber probe for in vivo clinical measurements of depth-resolved nuclear morphology. J Biomed Opt (2011) 1.39
Preventive therapy in perforated colonic diverticular disease? Calcium channel blockers may hold the key. Gastroenterology (2004) 1.39
Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol (2008) 1.38
Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol (2010) 1.37
Toward uniformity in the diagnosis of eosinophilic esophagitis (EoE): the effect of guidelines on variability of diagnostic criteria for EoE. Am J Gastroenterol (2011) 1.34
The use of carbon dioxide for insufflation during GI endoscopy: a systematic review. Gastrointest Endosc (2009) 1.32
Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology (2011) 1.29
Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance. Am J Physiol Gastrointest Liver Physiol (2007) 1.29
Developing a natural language processing application for measuring the quality of colonoscopy procedures. J Am Med Inform Assoc (2011) 1.28
Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology (2012) 1.28
Prevalence of esophageal eosinophilia varies by climate zone in the United States. Am J Gastroenterol (2012) 1.28
Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst (2013) 1.25
Impact of the 2008-2009 economic recession on screening colonoscopy utilization among the insured. Clin Gastroenterol Hepatol (2011) 1.21
Impact of comorbidity on colorectal cancer screening in the veterans healthcare system. Clin Gastroenterol Hepatol (2007) 1.21
Epidemiology and management of oesophageal coin impaction in children. Dig Liver Dis (2012) 1.18
Single-balloon enteroscopy: results from an initial experience at a U.S. tertiary-care center. Gastrointest Endosc (2010) 1.18
Quality indicators common to all GI endoscopic procedures. Gastrointest Endosc (2014) 1.17
Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagus. Clin Gastroenterol Hepatol (2012) 1.15
Association of industry sponsorship to published outcomes in gastrointestinal clinical research. Clin Gastroenterol Hepatol (2006) 1.15
Gastric electrical stimulation: "scoping" out new directions. Gastrointest Endosc (2007) 1.12
The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? Am J Gastroenterol (2003) 1.12
The role of radiofrequency ablation in the management of Barrett's esophagus. Gastrointest Endosc Clin N Am (2011) 1.11
De-novo onset of eosinophilic esophagitis after large volume allergen exposures. J Gastrointestin Liver Dis (2013) 1.10
Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure. AIDS (2013) 1.08
Variable reliability of endoscopic findings with white-light and narrow-band imaging for patients with suspected eosinophilic esophagitis. Clin Gastroenterol Hepatol (2011) 1.08
Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2013) 1.07
Differential gene expression in normal esophagus and Barrett's esophagus. J Gastroenterol (2009) 1.03
Quality of colonoscopy reporting: a process of care study. Am J Gastroenterol (2002) 1.03
Gastrointestinal endoscopy nurse experience and polyp detection during screening colonoscopy. Clin Gastroenterol Hepatol (2008) 1.03
A novel balloon pull-through technique for esophageal dilation in eosinophilic esophagitis (with video). Gastrointest Endosc (2011) 0.98
Diagnosis of eosinophilic esophagitis after fundoplication for 'refractory reflux': implications for preoperative evaluation. Dis Esophagus (2009) 0.98
Quality of life in GERD and Barrett's esophagus is related to gender and manifestation of disease. Am J Gastroenterol (2009) 0.98
Garlic, silver bullets, and surveillance upper endoscopy for Barrett's esophagus. Gastroenterology (2013) 0.97